Long Island’s Red, White & Blue Summer Soiree is a signature fundraising event bringing together 300+ professionals and philanthropic leaders for an unforgettable summer evening in support of the American Cancer Society.
Enjoy a high-energy night of bold bites, creative cocktails, music, and interactive experiences all while supporting the American Cancer Society and helping end cancer as we know it, for everyone.
Dr. Andrew Seidman is an Attending Physician for the Breast Medicine Service at Memorial Sloan Kettering Cancer Center, and Professor of Medicine at Weill Cornell Medical College. Dr. Seidman earned his medical degree from Hahnemann University School of Medicine in Philadelphia, Pennsylvania in 1985. He completed a residency in Internal Medicine at the Pennsylvania Hospital. Dr. Seidman then completed a fellowship in Medical Oncology and Hematology at Memorial Sloan Kettering Cancer Center in New York.
Dr. Seidman’s clinical research in the development of taxanes for breast cancer has impacted clinical care worldwide. He has authored or co-authored more than 200 peer-reviewed articles, reviews and book chapters, as well as over 160 abstracts, has served on the editorial boards of over a dozen leading oncology journals, and has lectured at innumerable national and international conferences and symposia on breast cancer related topics. Dr. Seidman is a Past-President of the American Society of Breast Disease, and the recipient of a Career Development Award from the American Society of Clinical Oncology (ASCO) for his work developing taxanes for breast cancer. He has received the Gay Clark Stoddard Award from the Susan G. Komen Foundation for excellent and compassionate care of patients with breast cancer, the Jacob Ehrenzeller Award from Pennsylvania Hospital for Academic Excellence and a Distinguished Alumnus Award from the Hahnemann University School of Medicine. He chaired a Working Group for the National Cancer Institute’s Breast Cancer Steering Committee on Meaningful and Appropriate Endpoints for Clinical Trials in Metastatic Breast Cancer (J Clin Oncol 2018). He serves on the ASCO Communications and Education Committees. At MSK, he has served as Associate Chair of Academic Administration, Medical Director of the Bobst International Center, and Senior Breast Cancer Advisor to the MSKCC-IBM Watson Collaboration. Dr. Seidman has served on the Oncology Drug Advisory Committee to the U.S. Food and Drug Administration. He currently leads an active translational research program focused on novel systemic treatment strategies for breast cancer brain metastases.
Heidi Sadowsky, RN, BSN, OCN®, CBCN®, came to nursing as a second career after 17 years in the financial services industry, where she always felt she had not yet found her true calling. That clarity came in 1996 during her father’s prolonged hospitalization, when she was deeply inspired by the compassion, skill, and presence of the nurses caring for him. Determined to pursue meaningful work, Heidi returned to school full time and became a registered nurse in 2008 — a decision she describes as life-changing and one she has never once questioned. She began her nursing career on an inpatient oncology unit, later worked as an infusion nurse, and for the past 12 years has specialized as an office practice nurse in breast medical oncology.
In her current role, Heidi provides extensive patient and family education, symptom management, psychosocial support, and patient navigation, while also guiding patients and families through end-of-life discussions and coordinating home care and hospice referrals. She is a facilitator and presenter of a two-day course designed to prepare nurses for the CBCN® certification exam and holds two national certifications: Oncology Certified Nurse (OCN®) and Certified Breast Care Nurse (CBCN®). Beyond her professional life, Heidi is a proud baseball mom to her 15-year-old son and a singer in two rock bands, bringing the same passion and heart to her personal pursuits that she brings to her work in oncology nursing.
For more than 10 decades, the American Cancer Society has been dedicated to pursuing better outcomes for every cancer, every life. Today, more people are surviving cancer than ever before, but there is still work to be done. Join us, support us, and help us end cancer as we know it, for everyone.
towards cancer research
winning scientists received research funding
through all patient support initiatives in 2024
